Reuters logo
BRIEF-Titan Pharmaceuticals reports Q3 loss per share of $0.20
November 9, 2017 / 12:46 PM / a month ago

BRIEF-Titan Pharmaceuticals reports Q3 loss per share of $0.20

Nov 9 (Reuters) - Titan Pharmaceuticals Inc

* Titan pharmaceuticals reports third quarter 2017 financial results

* Q3 loss per share $0.20

* ‍Titan is evaluating potential funding options​

* ‍At Sept. 30, had cash and cash equivalents of about $11.7 million, which co believes is sufficient to fund planned operations through Aug 2018​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below